The First Randomized Controlled Trial of Purified Palmitoleic Acid Supplementation in Humans March 9, 2015 13:09
Purified palmitoleic acid (16-1; omega-7), the power behind Cardia 7, has some exciting new study results and conclusions:
- Exerts potent anti-inflammatory and lipid-modulating effects compared with placebo.
- Appears to be important in regulating metabolism.
- May be useful in the treatment of hypertriglyceridemia with the beneficial added effects of decreasing LDL and hs-CRP and raising HDL.
The report of a study by Drs. Michael F. Roizen, MD and Adam M. Bernstein MD of the Wellness Institute of the Cleveland Clinic, “Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled study” is featured in the online September issue of the Journal of Clinical Lipidology and the October print version. http://www.lipidjournal.com/article/S1933-2874%2814%2900281-5/pdf
“These findings build on a growing body of in vitro, animal, and human studies, demonstrating the importance of palmitoleic acid to regulating metabolism. Thus, purified palmitoleic may be a therapeutic approach in helping maintain lipid levels within a healthy range as well as improving inflammatory markers in patients with mild dyslipidemia and inflammation,” state Drs. Roizen and Bernstein in their conclusions.
How do these findings compare with your Omega 7 experience? Help us help others by sharing your testimonial on our reviews page.